Sure, things go awry now and then. Trouble is, BOS doesn't seem...

Sure, things go awry now and then. Trouble is, BOS doesn't seem to inform the market when they become aware of trouble. Surely Biosignal knew CIBA was finding the compounds unworkable a lot sooner than today. Yet the enthusiastic and promising last announcement regarding CIBA was let stand.

I would welcome BOS being upfront and declare the feasibility of other applications. Do we have hope of success?

The seemingly most promising product is the oil and gas product. Unlike other products this has progressed with step-wise results announced to market. [The aircon trials in contrast is not discussed.] Yet, the delay on final outcomes from Commercial Microbiology have unnerved me.

Come on BOS, some up to date in depth news if you please.